Liniment Pharma Private Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Liniment Pharma Private Limited - overview
Established
2018
Location
Jaipur, Rajasthan, India
Primary Industry
Pharmaceuticals
About
Liniment Pharma Private Limited is a pharmaceutical technology company specializing in streamlining pharmacy procurement processes through an innovative platform that enhances order fulfillment and inventory management. Liniment Pharma Private Limited, founded in 2018 and headquartered in Jaipur, India, operates a technology platform to optimize procurement for pharmacies. The company has engaged in three funding deals, with its latest round occurring on September 27, 2021, when it raised USD 1 million in Seed funding from investors including Auxano and Faad Network. Founders Aastha Dusad, Rahul, and Rohit Bafna have experience in fostering technology-driven solutions in the pharmaceutical sector.
MEDdelivery™ offers a platform that automates the procurement process for pharmacies, providing access to over a million SKUs for efficient order fulfillment directly from preferred distributors. The service enhances order visibility and efficiency with real-time tracking and a digital returns process. Targeting a wide range of pharmacies across India, MEDdelivery facilitates credit-based purchasing options to help manage cash flow and inventory expansion, effectively serving more than 700,000 pharmacies in both metropolitan and rural areas. For the year 2023, Liniment Pharma Private Limited reported a revenue of USD 158,753.
2 and an EBITDA of USD -227,642. 8. The company generates revenue primarily through B2B transactions, utilizing an embedded credit system that encourages repeat purchases and increases average order value. Liniment Pharma Private Limited plans to leverage its recent Seed funding of USD 1 million raised in September 2021 to enhance product offerings and expand market reach.
The company aims to develop new features for its MEDdelivery™ platform, enhancing procurement capabilities for its pharmacy clients. Additionally, targeted expansions into new regional markets within India are planned to be executed by 2025, aimed at increasing their service footprint and client base.
Current Investors
LVX, Faad Network, Auxano
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceuticals
Website
www.meddelivery.in
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.